as soon as is submitted to ZB.
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion.
Z. Gastroenterol. 59, 691-776 (2021)
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
2.000
0.703
6
14
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Tenofovir Disoproxil Fumarate; Stem-cell Transplantation; E-antigen Seroconversion; Nucleos(t)ide Analog Therapy; Hbeag-negative Patients; Chronic Delta-hepatitis; Chronic Liver-disease; Persistently Normal Alt; Hbsag-positive Donors; Health-care Workers
Language
german
Publication Year
2021
HGF-reported in Year
2021
ISSN (print) / ISBN
0044-2739
e-ISSN
1439-7803
Quellenangaben
Volume: 59,
Issue: 7,
Pages: 691-776
Publisher
Thieme
Publishing Place
Rudigerstr 14, D-70469 Stuttgart, Germany
Reviewing status
Peer reviewed
Institute(s)
Institute of Virology (VIRO)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-003
WOS ID
WOS:000672932900022
Scopus ID
85110740590
PubMed ID
34255317
Erfassungsdatum
2021-08-02